Dana Klug, Chemistry PhD candidate, sits down with the College of Science Graduate Program staff to talk about what it’s like to work and study at Northeastern University.
Listen to chemistry professor Michael Pollastri talk about his work finding treatments for NTDs.
I first became interested in drugs to treat brain diseases with I was a pharmacy student at Northeastern in the early 1980s. After I got my PhD in medicinal chemistry at the University of California–San Francisco, I returned to Boston for a post-doctoral fellowship at Harvard Medical School. At the time, I was drawn to research on neurodegenerative diseases, such as Parkinson’s. But by 1987, I switched to neuropsychiatric diseases, and that’s what I’ve been focused on ever since.
Ninety percent of global healthcare and medical research money is spent on diseases that affect only 10 percent of the population, according to Michael Pollastri, a professor of chemistry and chemical biology who spoke at the College of Science Colloquium last Friday.